Aptagen, LLC
HA Clone B (ID# 8182)
RNA
Hemagglutinin of H3N2
Protein
115 pM (reported value)
0.01 M Hepes (pH 7.4), 0.15 M NaCl, 3 mM EDTA, and 0.005% Tween 20
22°C
NA If the oligo is a known aptamer sequence: For binding studies, perform a refolding protocol to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
No specificities tested.
5'-rGprGprGprAprGprAprAprUprUprCprCprGprAprCprCprAprGprAprAprGprGprGprUprUprAprGprCprGprGprUprCprGprUprCprUprUprAprAprGprUprAprGprUprUprUprUprUprGprGprUprCprCprUprUprUprCprCprUprCprUprCprUprCprCprUprUprCprCprUprCprUprUprCprUp-3'
74
22308.9
642000
Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.
Misono, T.S. and Kumar, P.K., 2005. Selection of RNA aptamers against human influenza virus hemagglutinin using surface plasmon resonance. Analytical biochemistry, 342(2), pp.312-317.
Have your aptamer oligo synthesized ORDER
We are always looking for ways to improve. Please tell us what you think.